Columnist: Carole Brendel, Ph.D.
Dr. Carole Brendel is a French native. She obtained a Ph.D. in Molecular Biology from the University of Strasbourg and the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC). Dr. Brendel served for four years as the Scientific Officer for the Alliance for European Diabetes Research (EURADIA), between 2003 and 2006. She contributed to the development of the Alliance’s advocacy and lobbying strategy, and acted as a scientific liaison with key opinion leaders. She currently holds a position of Senior Clinical Research Associate at PPD, a leading global contract research organization providing drug discovery, development and lifecycle management services.